Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10460623Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Biochemistry
- Internal Medicine
- Public Health
NIH Funding · FY2025
Linked Award Amount
$1.7M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#8,749
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Jeffrey Tornheim as a PI. Multi-PI records show the full award amount for context.
- 5R01AI175618-03R01Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood$722.5Kaward amount
- 5R01AI168371-03R01Baseline pRescription According to Direct from Sputum Sequencing and TArgeted drug Concentration Strategy (BRASS TACS)$364.8Kaward amount
- 2D43TW010074-11D43Infectious Diseases Training program in Bolivia: South-South-North Training with Peru and JHU$288.3Kaward amount
- 3R01AI168371-03S1R01Baseline pRescription According to Direct from Sputum Sequencing and TArgeted drug Concentration Strategy (BRASS TACS)$287.5Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Jeffrey Tornheim as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardJohns Hopkins University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #8749
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026Entered Top 25% NationallyRanked #4418
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jeffrey Tornheim.